Curcumin inhibits the neuroimmune response mediated by mast cells after pulpitis
DOI:
https://doi.org/10.1590/1678-7757-2023-0456Keywords:
Pulpitis, Mast Cells, Curcumin, NeuroimmuneAbstract
Objective: To analyze the effect of mast cells (MCs) in neurogenic inflammation and the neuroimmune response of trigeminal ganglia (TG) due to pulpitis and detect the regulatory effect of curcumin (Cur) on neuroimmune responses induced by pulpitis. Methodology: Immunohistochemistry, toluidine blue staining (TB), and other methods were used to detect the dynamic changes of MCs, as well as tryptase expression changes and protease activated receptor 2 (PAR2) and calcitonin gene-related peptide (CGRP) levels in the neuroimmune response induced by pulpitis. After administering Cur by intraperitoneal injection, the expression levels of Toll-like receptor 4 (TLR4), CGRP, glial fibrillary acidic protein (GFAP), fractalkine (CX3CL1), Tumor necrosis factor (TNF-α), and other factors were examined in the TG of pulpitis-induced rats. Results: After pulpitis induction, the expression of CGRP-positive neurons and GFAP-positive soluble guanylate cyclase (SGC) in the TG significantly increased. A large number of MCs underwent degranulation. MCs were scattered between the CGRP-positive nerve fibers. MCs showing a typical degranulated state within the TG significantly increased and tryptase-positive MCs surrounded the TG nerve fibers and neurons. After treatment with Cur, the inflammatory response in the periodontal bone induced by pulpitis decreased and promoted early tissue repair. The expression of TNF-α significantly decreased as did degranulation of MCs. In contrast, the expression of CGRP, TLR4-positive neurons, activated SGCs, and PAR2-positive TG neurons significantly decreased. MCs could participate in the neuroimmune response induced by pulpitis by the tryptase signaling pathway. Conclusion: Importantly, Cur inhibited the degranulation of MCs, downregulated the expression of tryptase and PAR2 in the TG, and attenuated the activation response of osteoclasts in the apical periodontium.
Downloads
References
Cavalla F, Reyes M, Vernal R, Alvarez C, Paredes R, García-Sesnich J, et al. High levels of CXC ligand 12/stromal cell-derived factor 1 in apical lesions of endodontic origin associated with mast cell infiltration. J Endod. 2013;39(10):1234-9. doi: 10.1016/j.joen.2013.06.020
Moura CC, Cunha TC, Crema VC, Dechichi P, Biffi JC. A study on biocompatibility of three endodontic sealers: intensity and duration of tissue irritation. Iran Endod J. 2014;9(2):137-43.
He J, Zhou Q, Jia X, Zhou P, Chen L. Immune-related expression profiles of bisphosphonates-related osteonecrosis of the jaw in multiple myeloma. Pharmazie. 2021;76(4):159-64. doi: 10.1691/ph.2021.01013
Cui L, Chen H, Zhao X. The prognostic significance of immune-related metabolic enzyme MTHFD2 in head and neck squamous cell carcinoma. Diagnostics (Basel). 2020;10(9):689. doi: 10.3390/diagnostics10090689
Fonseca TS, Silva GF, Guerreiro-Tanomaru JM, Sasso-Cerri E, Tanomaru-Filho M, Cerri PS. Mast cells and immunoexpression of FGF-1 and Ki-67 in rat subcutaneous tissue following the implantation of Biodentine and MTA Angelus. Int Endod J. 2019;52(1):54-67. doi: 10.1111/iej.12981
Dinakar G, Ganesh A, Kumar MP, Sabesan M, Narasimhan M, Deivanayagam K. Immunohistochemical quantification of mast cells in inflamed and noninflamed pulp tissue. J Oral Maxillofac Pathol. 2018;22(1):73-7. doi: 10.4103/jomfp.JOMFP_206_16
Mahita VN, Manjunatha BS, Shah R, Astekar M, Purohit S, Kovvuru S. Quantification and localization of mast cells in periapical lesions. Ann Med Health Sci Res. 2015;5(2):115-8. doi: 10.4103/2141-9248.153616
Lauritano D, Mastrangelo F, D’Ovidio C, Ronconi G, Caraffa A, Gallenga CE, et al. Activation of mast cells by neuropeptides: the role of pro-inflammatory and anti-inflammatory cytokines. Int J Mol Sci. 2023;24(5):4811. doi: 10.3390/ijms24054811
Bai R, Li M, Tian Z, Hu Y, An M, Yuan W, et al. Nanoparticulate chitosan-TNF-α-VLPs activate mast cells and enhance adaptive immunity induced by foot-and-mouth disease virus-like particles in mice. Vet Immunol Immunopathol. 2023;264:110662. doi: 10.1016/j.vetimm.2023.110662
Marek-Jozefowicz L, Nedoszytko B, Grochocka M, Żmijewski MA, Czajkowski R, Cubała WJ, et al. Molecular mechanisms of neurogenic inflammation of the Skin. Int J Mol Sci. 2023;24(5):5001. doi: 10.3390/ijms24055001
Balcziak LK, Russo AF. Dural immune cells, CGRP, and migraine. Front Neurol. 2022;13:874193. doi: 10.3389/fneur.2022.874193
Rees TA, Russo AF, O’Carroll SJ, Hay DL, Walker CS. CGRP and the calcitonin receptor are co-expressed in mouse, rat and human trigeminal ganglia neurons. Front Physiol. 2022;13:860037. doi: 10.3389/fphys.2022.860037
Iyengar S, Johnson KW, Ossipov MH, Aurora SK. CGRP and the trigeminal system in migraine. Headache. 2019;59(5):659-81. doi: 10.1111/head.13529
Akasaka R, Furukawa A, Hayashi Y, Hitomi S, Koyama R, Oshima E, et al. PAR2-dependent phosphorylation of TRPV4 at the trigeminal nerve terminals contributes to tongue cancer pain. J Oral Biosci. 2023;65(4):356-64. doi: 10.1016/j.job.2023.10.003
Dinh QT, Cryer A, Dinh S, Trevisani M, Georgiewa P, Chung F, et al. Protease-activated receptor 2 expression in trigeminal neurons innervating the rat nasal mucosa. Neuropeptides. 2005;39(5):461-6. doi: 10.1016/j.npep.2005.07.003
Zia A, Farkhondeh T, Pourbagher-Shahri AM, Samarghandian S. The role of curcumin in aging and senescence: molecular mechanisms. Biomed Pharmacother. 2021;134:111119. doi: 10.1016/j.biopha.2020.111119
Kotha RR, Luthria DL. Curcumin: biological, pharmaceutical,nutraceutical, and analytical aspects. Molecules. 2019;24(16):2930. doi: 10.3390/molecules24162930
Matsushita K, Motani R, Sakuta T, Nagaoka S, Matsuyama T, Abeyama K, et al. Lipopolysaccharide enhances the production of vascular endothelial growth factor by human pulp cells in culture. Infect Immun. 1999;67(4):1633-9. doi: 10.1128/IAI.67.4.1633-1639.1999
Alipour M, Fadakar S, Aghazadeh M, Salehi R, Samadi Kafil H, Roshangar L, et al. Synthesis, characterization, and evaluation of curcumin-loaded endodontic reparative material. J Biochem Mol Toxicol. 2021;35(9):e22854. doi: 10.1002/jbt.22854
Bommareddy CS, Ramkumar H, Dakshinamurthy S, Paulindraraj S, Jayakaran TG, Shankar K. Clinical and radiographic evaluation of curcumin as an obturation material in deciduous teeth: a randomized controlled trial. Int J Clin Pediatr Dent. 2022;15(Suppl 1):S35-s9. doi: 10.5005/jp-journals-10005-2128.
Kovanen PT, Bot I. Mast cells in atherosclerotic cardiovascular disease: activators and actions. Eur J Pharmacol. 2017;816:37-46. doi: 10.1016/j.ejphar.2017.10.013
Kaur G, Singh N, Jaggi AS. Mast cells in neuropathic pain: an increasing spectrum of their involvement in pathophysiology. Rev Neurosci. 2017;28(7):759-66. doi: 10.1515/revneuro-2017-0007
Cruse G, Bradding P. Mast cells in airway diseases and interstitial lung disease. Eur J Pharmacol. 2016;778:125-38. doi: 10.1016/j.ejphar.2015.04.046
DeBruin EJ, Gold M, Lo BC, Snyder K, Cait A, Lasic N, et al. Mast cells in human health and disease. Methods Mol Biol. 2015;1220:93-119. doi: 10.1007/978-1-4939-1568-2_7
Khalil WA, Abunasef SK. Can mineral trioxide aggregate and nanoparticulate endosequence root repair material produce injurious effects to rat subcutaneous tissues? J Endod. 2015;41(7):1151-6. doi: 10.1016/j.joen.2015.02.034
Kamal R, Dahiya P, Goyal N, Kumar M, Sharma N, Saini HR. Mast cells and oral pathologies: a review. J Nat Sci Biol Med. 2015;6(1):35-9. doi: 10.4103/0976-9668.149075
Kritikou E, Kuiper J, Kovanen PT, Bot I. The impact of mast cells on cardiovascular diseases. Eur J Pharmacol. 2016;778:103-15. doi: 10.1016/j.ejphar.2015.04.050
Reber LL, Frossard N. Targeting mast cells in inflammatory diseases. Pharmacol Ther. 2014;142(3):416-35. doi: 10.1016/j.pharmthera.2014.01.004
Nigrovic PA, Lee DM. Mast cells in inflammatory arthritis. Arthritis Res Ther. 2005;7(1):1-11. doi: 10.1186/ar1446
Li N, Guo Y, Gong Y, Zhang Y, Fan W, Yao K, et al. The anti-inflammatory actions and mechanisms of acupuncture from acupoint to target organs via neuro-immune regulation. J Inflamm Res. 2021;14:7191-224. doi: 10.2147/JIR.S341581
Jia L, Lee S, Tierney JA, Elmquist JK, Burton MD, Gautron L. TLR4 Signaling selectively and directly promotes cgrp release from vagal afferents in the mouse. eNeuro. 2021;8(1):ENEURO.0254-20.2020. doi: 10.1523/ENEURO.0254-20.2020
Vindiš B, Gašperšič R, Skalerič U, Kovačič U. Toll-like receptor 4 expression in trigeminal neurons is increased during ligature-induced periodontitis in rats. J Periodontol. 2014;85(1):170-7. doi: 10.1902/jop.2013.130039
Moore ER, Michot B, Erdogan O, Ba A, Gibbs JL, Yang Y. CGRP and Shh mediate the dental pulp cell response to neuron stimulation. J Dent Res. 2022;101(9):1119-26. doi: 10.1177/00220345221086858
Jia T, Rao J, Zou L, Zhao S, Yi Z, Wu B, et al. Nanoparticle-encapsulated curcumin inhibits diabetic neuropathic pain involving the P2Y12 receptor in the dorsal root ganglia. Front Neurosci. 2018;11:755. doi: 10.3389/fnins.2017.00755
Lv Y, Zhao Y, Wang X, Chen N, Mao F, Teng Y, et al. Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-α-PD-L1 pathway. J Immunother Cancer. 2019;7(1):54. doi: 10.1186/s40425-019-0530-3
Conti P, Lauritano D, Caraffa A, Gallenga CE, Carinci F, Ronconi G, et al. Mast cells mediate rheumatoid arthritis-inhibitory role of IL-37. Crit Rev Immunol. 2019;39(4):267-74. doi: 10.1615/CritRevImmunol.2020033176
Downloads
Published
Versions
- 2024-10-01 (2)
- 2024-09-16 (1)
Issue
Section
License
Copyright (c) 2024 Ming Dong, Jing Tang, Lu-Jia Li, Ting Dai, Yi-Yan Zuo, Hai-Wei Jin
This work is licensed under a Creative Commons Attribution 4.0 International License.
Todo o conteúdo do periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons do tipo atribuição CC-BY.
